HAIMBIO
HaimBio is a drug development company. Their flagship product, Starvanip, is a metabolism-based cancer therapy that kills cancer cells by starving them of metabolic energy. Starvanip inhibits cancer cell growth and induces apoptosis -- the death of cancer cells. It does this by inhibiting the energy source of cancer cells, dramatically reducing side effects such as harm to normal cells and reducing the toxicity of current anticancer therapies. The drug will also improve the rate of response and target a wider range of cancers. Tests have demonstrated efficacy with 12 types of cancer, as well as significant reductions of tumor sizes and increases of cancer cell death with almost no death of normal cells.
HAIMBIO
Social Links:
Industry:
Biotechnology Medical
Founded:
2011-09-26
Address:
Seoul, Seoul-t'ukpyolsi, South Korea
Country:
South Korea
Website Url:
http://www.en.haimbio.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
3 M KRW
Technology used in webpage:
SPF ASP.NET IIS IIS 10 Japanese Yen GlobalSign Classic ASP Naver Analytics
Similar Organizations
Scholar Rock
Scholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases.
Current Advisors List
Current Employees Featured
Founder
Official Site Inspections
http://www.en.haimbio.com
- Host name: 211.47.74.128
- IP address: 211.47.74.128
- Location: South Korea
- Latitude: 37.5112
- Longitude: 126.9741
- Timezone: Asia/Seoul
